XML 49 R39.htm IDEA: XBRL DOCUMENT v3.24.3
Financial Instruments (Schedule of Reconciliation of Contingent Consideration) (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Contingent Consideration        
Change in valuation     $ 12,170 $ (21,900)
Ascyrus Medical LLC        
Contingent Consideration        
Change in valuation $ (3,500) $ (6,200) 12,200 $ (21,900)
Ascyrus Medical LLC | Level 3        
Contingent Consideration        
Beginning balance     (63,890)  
Change in valuation     12,170  
Ending balance $ (51,720)   $ (51,720)